ISRG · Earnings call · 2026Q3T · Full report

Products and Technology

INTUITIVE SURGICAL INC · 2026-10-20 · Importance 34 · Surprise 42 · In source text

Intuitive received CE marks for Force Feedback instrumentation and cardiac procedures on da Vinci 5, and for transvaginal gynecological procedures on SP; da Vinci 5 cardiac clearance now covers the U.S., Europe, India, Japan, and Korea. FDA clearances for surgeon-initiated tool eject and multi-arm targeting were described as adding efficiency and surgeon autonomy, while a handheld endoscope received FDA clearance. The company also received FDA clearance for a foundational, noncommercial next-generation flexible robotic endoscope for gastrointestinal use and submitted a cavitational ultrasonic aspirator for liver and pancreas procedures. Management said it is developing a voice-activated interface and automated fourth-arm control for da Vinci 5, while telepresence supports future telesurgery efforts.

Key facts

Impact estimates

metricdirectionstageexpectedbasis
revenuepositiveprobable—Intuitive has two active Ion development programs: a ROSE system for on-site cytology and endobronchial ultrasound integrated into Ion for…